Comparing STRATA Skin Sciences (NASDAQ:SSKN) & United American Healthcare (OTCMKTS:UAHC)

United American Healthcare (OTCMKTS:UAHC) and STRATA Skin Sciences (NASDAQ:SSKN) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Volatility & Risk

United American Healthcare has a beta of -1.4, indicating that its stock price is 240% less volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.

Earnings and Valuation

This table compares United American Healthcare and STRATA Skin Sciences’ top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United American Healthcare	N/A	N/A	N/A	N/A	N/A
STRATA Skin Sciences	$32.55 million	0.36	-$10.83 million	($3.30)	-1.01

United American Healthcare has higher earnings, but lower revenue than STRATA Skin Sciences.

Profitability

This table compares United American Healthcare and STRATA Skin Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
United American Healthcare	N/A	N/A	N/A
STRATA Skin Sciences	-34.92%	-65.76%	-19.69%

Institutional & Insider Ownership

32.4% of STRATA Skin Sciences shares are owned by institutional investors. 14.3% of United American Healthcare shares are owned by company insiders. Comparatively, 40.4% of STRATA Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations and price targets for United American Healthcare and STRATA Skin Sciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United American Healthcare	0	0	0	0	N/A
STRATA Skin Sciences	0	0	0	0	N/A

STRATA Skin Sciences has a consensus target price of $38.00, indicating a potential upside of 1,037.72%. Given STRATA Skin Sciences’ higher probable upside, analysts clearly believe STRATA Skin Sciences is more favorable than United American Healthcare.

Summary

STRATA Skin Sciences beats United American Healthcare on 5 of the 8 factors compared between the two stocks.

About United American Healthcare

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.